Cardiac involvement in patients with myeloproliferative disorders.

[1]  W. Markiewicz,et al.  Cardiac involvement in patients with primary antiphospholipid syndrome. , 1991, Journal of the American College of Cardiology.

[2]  M. Nicholls,et al.  Cardiac involvement in systemic lupus erythematosus detected by echocardiography. , 1990, The American journal of cardiology.

[3]  T. Barbui,et al.  Hemostatic complications in young patients with essential thrombocythemia. , 1990, The American journal of medicine.

[4]  B. Brenner,et al.  Abnormalities of fibrinolytic parameters in patients with myeloproliferative diseases , 1990 .

[5]  M. Lockshin,et al.  Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. , 1989, The American journal of medicine.

[6]  A. Wehmeier,et al.  Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease. , 1989, Haemostasis.

[7]  A. Nagler,et al.  Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. , 1988, Archives of internal medicine.

[8]  G. Maurer,et al.  Echocardiographic findings in systemic lupus erythematosus. , 1988, The American journal of cardiology.

[9]  W. Lubbe,et al.  Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. , 1988, The Journal of rheumatology.

[10]  I. Palacios,et al.  Mitral regurgitation after percutaneous balloon mitral valvuloplasty in adults: evaluation by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.

[11]  P. Mugnier,et al.  Polycythaemia vera in young people: an analysis of 58 cases diagnosed before 40 years , 1987, British journal of haematology.

[12]  B. Brenner,et al.  Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia. , 1987, Haemostasis.

[13]  R. Berger,et al.  Essential thrombocythemias. Clinical evolutionary and biological data , 1986, Cancer.

[14]  J. Goldberg,et al.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. , 1986, Seminars in hematology.

[15]  D. Valla,et al.  Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. , 1985, Annals of internal medicine.

[16]  R. Davis,et al.  Acute thrombotic complications of myeloproliferative disorders in young adults. , 1985, American journal of clinical pathology.

[17]  A. Van Tosh,et al.  Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.

[18]  B. Amor,et al.  Libman-Sacks endocarditis: the diagnostic importance of two-dimensional echocardiography. , 1985, British journal of rheumatology.

[19]  J. Steketee,et al.  Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. , 1985, Annals of internal medicine.

[20]  A. Dawson,et al.  Measurement of platelet life‐span in normal subjects and patients with myeloproliferative disease with indium oxine labelled platelets , 1984, British journal of haematology.

[21]  Z. Ruggeri,et al.  Acquired von Willebrand's disease in the myeloproliferative syndrome. , 1984, Blood.

[22]  A. Schafer.  Bleeding and thrombosis in the myeloproliferative disorders. , 1984, Blood.

[23]  E. Massey,et al.  Neurologic manifestations of essential thrombocythemia. , 1983, Annals of internal medicine.

[24]  E. Ladusans,et al.  Lacunar infarcts in polycythaemia with raised packed cell volumes. , 1983, British medical journal.

[25]  A S Abbasi,et al.  Pulsed Doppler echocardiography in the diagnosis and estimation of severity of aortic insufficiency. , 1982, The American journal of cardiology.

[26]  B. Sandok,et al.  Two-dimensional echocardiography in patients with focal cerebral ischemia. , 1981, Annals of internal medicine.

[27]  D. Decristofaro,et al.  Detection and Estimation of the Degree of Mitral Regurgitation by Range‐gated Pulsed Doppler Echocardiography , 1980, Circulation.

[28]  R. Virmani,et al.  Thrombocytosis, coronary thrombosis and acute myocardial infarction. , 1979, The American journal of medicine.

[29]  R. Purcell,et al.  The chronic sequelae of non-A, non-B hepatitis. , 1979, Annals of internal medicine.

[30]  T. Pearson,et al.  VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX , 1978, The Lancet.

[31]  S Simonsen,et al.  Determination of Pressure Gradient in Mitral Stenosis with a Non‐invasive Ultrasound Doppler Technique , 2009 .

[32]  A. Theologides,et al.  ACETYLSPERMIDINES IN HUMAN URINE , 1975, The Lancet.

[33]  B. Bulkley,et al.  Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. , 1975, The American journal of medicine.

[34]  W. Roberts,et al.  Systemic lupus erythematosus as a cause of severe mitral regurgitation. New problem in an old disease. , 1975, The American journal of cardiology.

[35]  L. Wasserman,et al.  Abnormalities of platelet function in patients with polycythemia vera. , 1973, Cancer research.

[36]  A. Dawson,et al.  The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera , 1970, Postgraduate medical journal.

[37]  J. Fairbairn,et al.  Erythermalgia: Review of 51 Cases , 1964, Circulation.

[38]  T. Thiede,et al.  Complications and causes of death in polycythaemia vera. , 2009, Acta medica Scandinavica.

[39]  E. Libman,et al.  A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS , 1924 .